Topsoe Jakob Haldor's Form 4 filing
IGM Biosciences, Inc. (IGMS) · filed Jul 3, 2023
- Accession no.
- 0001209191-23-040700
- Filed
- Jul 3, 2023
- Trade date
- Jun 29-30, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market purchases total $64.2K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Topsoe Jakob HaldorCIK 0001785882 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 29, 2023 | Common Stock | PPurchaseAcquired | +3,500 | $9.10 | +$31,850 | 78,144 | Direct | |
| Jun 30, 2023 | Common Stock | PPurchaseAcquired | +3,500 | $9.25 | +$32,375 | 81,644 | Direct | |
| Jun 30, 2023 | Common Stock | AGrant or awardAcquired | +492 | $0.00 | $0 | 82,136 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.